Literature DB >> 16130394

[Study on culture and in vitro osteogenesis of blood-derived human mesenchymal stem cells].

Cong Cao1, Yinghai Dong, Yuqi Dong.   

Abstract

OBJECTIVE: To establish a method of isolating and culturing adult human blood-derived stem cells(MSCs) and to investigate their osteogenic potential in vitro.
METHODS: Thirty peripheral blood collected from 30 adult volunteers (15 ml per person). Adult human MSCs derived from peripheral blood from the lymphocyte separation fluid fraction of mononuclear cells, cultured in alpha-Modified Eagle's Medium glucose containing 20% fetal bovine serum, and proliferated through a process of subculturing. The phenotype was analyzed with flow cytometry. For in vitro osteogenic differentiation, MSCs from the second passage presence of osteogenic supplements (100 nmol/L dexamethasone,10 mmol/L beta-glycerophosphate, 50 micromol/L and 10 nmol/L 1,25-2-hydroxide vitamin D3). In the fifth passage cells, the activity of alkaline phosphatase, expression level of collagen type I, osteocalcin and osteonectin were determined. And the calcium tubercle would be examined after the continual one-month culture of the fifth passage.
RESULTS: MSCs existed in blood of adult human. And the clone forming efficiency of blood-derived MSCs was 0.27 +/- 0.22/10(6) mononuclear The MSCs expressed CD44,CD54,CD105,and CD166, but did not CD14, CD34, CD45,and CD31. Under osteogenic supplements, the MSCs were found to be higher activity of alkaline phosphatase and higher expression of collagen type I , osteocalcin and osteonectin. And the calcium tubercle formation was examined through fluorescence labeling method.
CONCLUSION: The isolation and culture conditions established for adult human select a distinct population of peripheral blood-derived adherent cells. Adult human blood-derived osteogenic potential in vitro, and may be used as seed cells for bone tissue engineering.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16130394

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  14 in total

1.  Induction of multipotency in umbilical cord-derived mesenchymal stem cells cultivated under suspension conditions.

Authors:  Fatemeh Amiri; Raheleh Halabian; Morteza Salimian; Mohammad Ali Shokrgozar; Masoud Soleimani; Ali Jahanian-Najafabadi; Mehryar Habibi Roudkenar
Journal:  Cell Stress Chaperones       Date:  2014-01-26       Impact factor: 3.667

Review 2.  Mesenchymal Stem Cells in the Musculoskeletal System: From Animal Models to Human Tissue Regeneration?

Authors:  Klemen Čamernik; Ariana Barlič; Matej Drobnič; Janja Marc; Matjaž Jeras; Janja Zupan
Journal:  Stem Cell Rev Rep       Date:  2018-06       Impact factor: 5.739

3.  Mesenchymal stem cells from the retropatellar fat pad and peripheral blood stimulate ACL fibroblast migration, proliferation, and collagen gene expression.

Authors:  B L Proffen; C M Haslauer; C E Harris; M M Murray
Journal:  Connect Tissue Res       Date:  2012-08-23       Impact factor: 3.417

Review 4.  Sinking Our Teeth in Getting Dental Stem Cells to Clinics for Bone Regeneration.

Authors:  Sarah Hani Shoushrah; Janis Lisa Transfeld; Christian Horst Tonk; Dominik Büchner; Steffen Witzleben; Martin A Sieber; Margit Schulze; Edda Tobiasch
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

5.  Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC.

Authors:  Ralf Hass; Cornelia Kasper; Stefanie Böhm; Roland Jacobs
Journal:  Cell Commun Signal       Date:  2011-05-14       Impact factor: 5.712

6.  Immunomodulatory effects of mesenchymal stromal cells revisited in the context of inflammatory cardiomyopathy.

Authors:  Kapka Miteva; Sophie Van Linthout; Hans-Dieter Volk; Carsten Tschöpe
Journal:  Stem Cells Int       Date:  2013-06-19       Impact factor: 5.443

Review 7.  Mesenchymal stem cells derived in vitro transdifferentiated insulin-producing cells: A new approach to treat type 1 diabetes.

Authors:  Shruti Dave
Journal:  Adv Biomed Res       Date:  2014-12-31

Review 8.  Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015).

Authors:  Aastha Singh; Abhishek Singh; Dwaipayan Sen
Journal:  Stem Cell Res Ther       Date:  2016-06-04       Impact factor: 6.832

Review 9.  Chondromalacia patellae: current options and emerging cell therapies.

Authors:  Weitao Zheng; Hanluo Li; Kanghong Hu; Liming Li; Mingjian Bei
Journal:  Stem Cell Res Ther       Date:  2021-07-18       Impact factor: 6.832

10.  Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment.

Authors:  Ralf Hass; Anna Otte
Journal:  Cell Commun Signal       Date:  2012-09-03       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.